ADVERTISEMENT
ADVERTISEMENT
artistic rendering of CRISPR/Cas9
Ten Years of CRISPR
This month marks ten years since CRISPR-Cas9 was repurposed as a gene editing system, so we’re looking back at what has been accomplished in a decade of CRISPR editing.
Ten Years of CRISPR
Ten Years of CRISPR

This month marks ten years since CRISPR-Cas9 was repurposed as a gene editing system, so we’re looking back at what has been accomplished in a decade of CRISPR editing.

This month marks ten years since CRISPR-Cas9 was repurposed as a gene editing system, so we’re looking back at what has been accomplished in a decade of CRISPR editing.

CRISPR patent
Vector illustration of a courthouse with test tubes as pillars
CRISPR Patent Ruling Favors Broad Institute
Jef Akst | Mar 1, 2022 | 3 min read
The US Patent and Trademark Office has once again decided that the institute has priority over the University of California and collaborators regarding intellectual property rights for CRISPR-Cas9 gene editing in eukaryotes. But the fight over the technique isn’t over.
Biden Names Geneticist Eric Lander as Top Science Adviser
Max Kozlov | Jan 18, 2021 | 3 min read
If confirmed, Lander will head the Office of Science and Technology Policy, a position that President Donald Trump left vacant for 18 months at the beginning of his term.
A Brief Guide to the Current CRISPR Landscape
Diana Kwon | Jul 15, 2019 | 5 min read
Hundreds of CRISPR patents have been granted around the world, and the number of applications continues to grow at a rapid pace.
USPTO Restarts CRISPR Patent Dispute Between Broad and UC
Jef Akst | Jun 26, 2019 | 2 min read
The US patent office declares an interference between the intellectual property held by the Broad Institute and several patent applications filed by the University of California—opposite its previous ruling.
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018 | 2 min read
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018 | 2 min read
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
Berkeley CRISPR Inventors Get Another Important European Patent
Jim Daley | Mar 12, 2018 | 2 min read
This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017 | 10 min read
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
UC Berkeley: Patent Office “Ignored Key Evidence”
Jef Akst | Jul 26, 2017 | 3 min read
The University of California files a brief in its appeal challenging the ruling that the Broad Institute’s group would retain its CRISPR genome-editing patent.
Major CRISPR Patent-Holders Agree to Patent Pool
Aggie Mika | Jul 10, 2017 | 2 min read
The Broad Institute and others sign on to participate in a platform designed to streamline the licensing process. 
UC Berkeley Receives CRISPR Patent in Europe
Jef Akst | Mar 24, 2017 | 4 min read
The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.
Broad Wins CRISPR Patent Interference Case
Jef Akst | Feb 15, 2017 | 3 min read
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
Life Science Controversies of 2016
Bob Grant, Jef Akst, and Tracy Vence | Dec 23, 2016 | 5 min read
This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.
Video: Patent Battle Over CRISPR Gene Editing
Jef Akst | Dec 13, 2016 | 1 min read
The Scientist goes to court for a CRISPR patent interference case at the US Patent and Trademark Office.
New Developments in CRISPR Patent Case
Jef Akst | Dec 12, 2016 | 2 min read
Documents suggest Feng Zhang started working on CRISPR before Jennifer Doudna’s group published; researchers call for CRISPR technology to be shared openly
CRISPR Oral Arguments Recap, Cont’d
Jef Akst | Dec 7, 2016 | 5 min read
This week’s CRISPR patent hearing took a deep dive into the science of moving the gene-editing technology from prokaryotes to eukaryotic systems.
USPTO to Hear Arguments on CRISPR Patents
Jef Akst | Dec 5, 2016 | 2 min read
Tuesday morning, the US Patent and Trademark Office will hear oral arguments from the two parties that claim to have been the first to use CRISPR-Cas9 gene editing technology in eukaryotic cells.
ADVERTISEMENT